Skip to content
healthcare.dev

Daraprim

NDC 69413-330, pyrimethamine, tablet, from Vyera Pharmaceuticals LLC.

Product NDC
69413-330
Status
Listed
Labeler
Vyera Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA008578
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69413-330 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIMETHAMINE25 mg/1

Pharmacologic classes

Dihydrofolate Reductase Inhibitor Antimalarial [EPC]; Dihydrofolate Reductase Inhibitors [MoA]

Package NDCNDC-11Package
69413-330-1069413033010100 TABLET in 1 BOTTLE, PLASTIC (69413-330-10)
69413-330-306941303303030 TABLET in 1 BOTTLE, PLASTIC (69413-330-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5368616d-6520-6f6e-2053-686b72656c69

Use it

Look up 69413-330 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69413-330 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69413-330. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.